It's starting to look, to me anyway, that the Covid trial is now a non-starter and that BoM2 is where the company needs to focus its energies to be viable long term. So, does the company issue a PR saying that the trial isn't progressing or just not address it at all?  Tricky.  Then we have the financing factor for BoM2 and the fact that we're still in a Covid environment.  If we we had a solid financial backer and a new CEO to navigate us through to BoM2 it would be a different story.